Dexcom (DXCM) is in talks to buy out diabetes device maker Insulet Corp (PODD), according to Bloomberg reports.

Dexcom to acquire Insulet- Diabetic Device

The two companies are currently negotiating the deal and an agreement could be reached over the following weeks.

Dexcom to acquire Insulet- Negotiations

Insulet and Dexcom had market valuations of $14.1 billion and $31.8 billion, respectively.

Dexcom to acquire Insulet- Market Value

Dexcom and Insulet come in the midst of a significant slowdown in dealmaking in the healthcare sector.

Dexcom to acquire Insulet- Healthcare Sector

Healthcare companies have participated in $103 billion worth of deals in 2022, down 45% year-over-year.

Dexcom to acquire Insulet- Healthcare Worth

Dexcom and Insulet already have a partnership through which Insulet’s delivery system integrates into Dexcom’s glucose.

Dexcom to acquire Insulet- System Inegrates

The deal would provide Dexcom with a closed-loop system to diabetes patients both diagnosis and treatment services.

Dexcom to acquire Insulet- Closed Loop System

The Report sent Insulent shares up 10% in pre-market trading Tuesday. Dexcom shares are down over 7% on the other hand.

Dexcom to acquire Insulet- Share Reaction

Swipe up for More Stories related to Tchnology, Gadgets, Finance, & Other Trending News  around the Globe.

Dexcom to acquire Insulet- Swipe Up!!!